- Primary Antibodies
-
ELISA Kits
- Infectious Disease ELISA Kits
- Parasitology ELISA kits
- Normalization ELISA Kits
- Kidney Injury Biomarker ELISA Kits
- Human ELISA Kits
- Rat ELISA Kits
- Mouse ELISA Kits
- Bovine ELISA Kits
- Porcine Protein ELISA Kits
- Chicken Protein ELISA Kits
- Dog/Canine ELISA Kits
- Small Molecules ELISA Kits
- Monkey & other ELISA Kits
- Food ELISA Kits
- Autoimmune Disease ELISA Kits
- Cancer Biomarker ELISA Kits
- Steroids ELISA Kits
-
Proteins
- Recombinant Proteins
- Growth Factors
- Cancer
- Cardiology
- Cell structure protein
- Developmental Biology
- DNA/RNA Emyzme
- Endocrinology
- Epigenetic erasers
- Epigenetic readers
- Epigenetic writers
- Extracellular Matrix
- Gastrointestinal Diseases
- Glycobiology
- Haemetology
- Hematology
- Immunology
- Infectious disease
- Inflammation
- Metabolism
- Motorsystem
- Neuroscience
- Other
- Proteases
- Signaling Pathway
- Transcription Factor
- Ubiquitin
- Urology
- CRISPR/Cas9 Protein
- Peptides
- Reagents
-
Services
- Recombinant protein expression and purification (NB-SC101)
- Antibody Services (NB-SC102)
- ELISA Assay Development (NB-SC103)
- Antibody Pair Screening (NB-SC104)
- AlphaLisa™ and Alphascreen™ Assays (NB-SC105)
- Hybridoma Sequencing (NB-SC106)
- Development of an AlphaLisa assay for Screening Histone Methyltransferase Inhibitors (NB-SC107)
- Ultrasensitive ELISA/ ImmunoPCR (NB-SC108)
- Generation of Stable Cell Lines Expressing Antibodies (NB-SC109)
- Antibody Sequencing/ Recombinant Antibody Production (NB-SC110)
- Antibody Conjugation Services (NB-SC111)
- ELISA Testing services (NB-SC112)
- Western Blot Service (NB-SC113)
- Protocols
-
News
-
News
- Novatein Biosciences Introduces the Human Anti-Carbamylated Protein Antibody (Anti-CarP) ELISA Kit
- Launch of immunoPCR assay development and antibody-DNA conjugation services
- Novatein Biosciences launched antigen and antibodies products for the 2019-nCoV/COVIS-19/SARS-COV2 research.
- NovaTeinBio Introduce Hundreds of New ELISA Kit Products Through Their Company Catalogue
- NovaTeinBio Advancing Research with New CD Antigen Solutions
- NovaTeinBio Adds New Antibodies to Company Catalogue
- NovaTeinBio Add Protein Expression and Purification to Their Service Catalogue
- NovaTeinBio Announces Discount on New Human PEG 20000 ELISA Kit
- Food ELISA kits
- NovaTeinBio Now Offering Wider Range of ELISA Kit Testing Solutions
- Cancer Biomarker ELISA kits
- Reliable Detection of CRISPR Activity Using Cas9 Monoclonal Antibodies
- How Do Cas9 Monoclonal Antibodies Improve CRISPR Validation Accuracy?
- Why ELISA Kits Are Essential for Steroid Testing in Clinical Studies
- How to Optimize Your Workflow Using the Human CEA ELISA Kit
- Why Penicillin ELISA Kits Are Critical in Dairy Product Screening
- How Human CD161 Antibody Research Advances Immunology Insights
- OVA sIgG ELISA Kits: Measuring Immune Response Made Simple
- Why Gluten ELISA Testing Is Crucial for Celiac-Safe Products
- Why Penicillin ELISA Testing Remains Critical in Food Safety Programs
- Quantifying Human Lipoproteins in Serum Using ELISA Technology
- What Is CBX3 Antibody Used For in Epigenetics Studies?
- Canine beta NGF ELISA Kit 96T: Accurate Detection for Veterinary Research
- What's Porcine Luteinizing Hormone and How's It Used
- Best Practices for Using a CRISPR/Cas9 Host Autoantibody ELISA Kit
- How to Choose the Right Human Ovalbumin IgG ELISA Kit
- How CD161 Antibodies Help Study Immune Cell Populations
- Novatein Biosciences Launches Redesigned Website to Enhance Access to Life Science Research Products and Services
- News Letters
- Product Citations
-
News
- Distributors
-
Support
Human Complement C3a des Arg ELISA kit
Catalog # FM-CE100021
Assay Range | 312.5 - 20,000 pg/mL |
Sensitivity | 50 pg/mL |
Size | 96T |
Storage | Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC |
Assay Principle | Competitive ELISA |
Sample volume | 100 µL final volume, dilution factor varies on samples. |
Detection Method | Chromogenic |
Kit Components
1. Recombinant Human C3a des Arg standard: 2 vials.
2. One 96-well plate precoated with Goat anti-Rabbit IgG
3. Assay buffer (10x): 15 mL x1
4. AP-Conjugate Reagent: 6 mL x1
5. Rabbit anti- Human C3a des Arg Ab: 6 mL x1
6. Complement Reagent A: 15 mL x1
7. Complement Reagent B: 30 mL x1
8. pNpp Substrate: 20 mL x1
9. Stop solution: 6 mL x1.
10. Washing solution (20x): 30 mL x1.
Background
C3a is a member of the anaphylatoxin family of three proteins (C3a, C4a and C5a) produced by the activation of complement. The des Arg form of C3a is an unglycosylated polypeptide. The activities of C3a are inactivated by removal of the C-terminal arginine by carboxypeptidase. Human Complement C3a des Arg contains 77 amino acids with 6 cysteines forming disulfide bridges at residues 22-49, 23-56 and 36-57. The C-terminal end of Complement C3a des Arg in Human, guinea pig, mouse and rat, is identical. Complement C3a des Arg is a highly cationic molecule. C3a is one of the most potent constrictors of smooth muscle cells, and guinea pig airways are hyper-responsive to C3a when pretreated with histamine. New activities have been identified for C3a des Arg acting through the C5L2 receptor. The use of potent protease inhibitors, such as Futhan, in conjunction with EDTA, may allow complement activation factors to be quantitated specifically via inhibition of non-specific protease formation of Complement C3a des Arg.